Showing 2039 results
-
Clinical Trials /
-
Clinical Trials /
-
Press release /Novartis agrees to take actions aimed at meeting US Administration priorities for drug pricingAdditional Novartis medicines will be made available through direct-to-patient platforms in 2026Company…
-
Story /Accelerating Research to Get Answers Faster
-
Media Library / -
Story /Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.
-
Featured News /
Patient community representatives call for improved digital health literacy, standardised digital platforms, and co-creation of digital solutions.
-
Featured News /
-
Press release /Promacta receives FDA Priority Review for first-line treatment of SAA based on data showing 52% complete response rate and 85% overall response rate when added to standard immunosuppressive therapy (…
-
Ad hoc release /Pooled analyses of LUSTER 1 and 2 did not support further development of Fevipiprant in asthma as a primary indication Fevipiprant was well tolerated with adverse events balanced across…